Rockville, MD, USA, July 03, 2017 (GLOBE NEWSWIRE) -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will address the global regulatory community on 10 September, delivering the opening keynote remarks at the 2017 Regulatory Convergence conference at National Harbor on the DC Waterfront. The Convergence is the largest annual meeting of healthcare product regulatory professionals and the signature annual event of the Regulatory Affairs Professionals Society (RAPS). It will take place 9–12 September at the Gaylord National Resort and Convention Center, National Harbor.
“Dr. Gottlieb has always been passionate and outspoken on public health policy, and we eagerly look forward to hearing directly from him on his vision for FDA and the overall direction of healthcare,” said RAPS Executive Director Paul Brooks. “RAPS is honored to have Dr. Gottlieb for one of his first large-scale public appearances as commissioner. I can’t think of a more fitting speaker to kick off our gathering of regulatory professionals from around the world.”
Gottlieb became the 23rd FDA commissioner in May. In his initial speech to agency staff, he called this “a time of great promise” for healthcare. Since taking over as head of FDA, he has identified addressing the national opioid addiction crisis, and increasing generic drug competition and speeding new generics to market as among his top priorities.
Gottlieb has an extensive resume, having worked in many prominent public health roles. He is a physician, medical policy expert and public health advocate who previously served as FDA’s deputy commissioner for medical and scientific affairs and before that, as a senior advisor to the commissioner. Prior to being sworn in as FDA commissioner, he was a resident fellow at the American Enterprise Institute and a clinical assistant professor at the New York University School of Medicine.
Members of the media who wish to cover all or part of RAPS’ Regulatory Convergence should contact Zachary Brousseau, senior manager, communications for RAPS at zbrousseau@raps.org or +1 301 770 2920, ext. 245.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6c6d1da7-c467-46b7-b969-2e25ebc67464
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2af00ae2-b373-4beb-9afd-3c14d3b87fa6